Navigation Links
New Spanish-Language Consumer Guide Compares Oral Diabetes Medications
Date:6/19/2008

ROCKVILLE, Md., June 19 /PRNewswire-USNewswire/ -- Pastillas para la diabetes tipo 2, a new consumer guide for Hispanic adults who have type 2 diabetes and need information to help them compare various oral medications for their illness, has been released by the Agency for Healthcare Research and Quality.

Diabetes is one of the most serious health issues facing Hispanics in the United States. AHRQ data show that nearly one in eight Hispanics take a prescription drug for diabetes.

"This guide offers critically important information to help Hispanics who have diabetes control their disease and avoid side effects," said AHRQ Director Carolyn M. Clancy, M.D. She added that providing information in Spanish will help efforts to get Hispanic patients more involved in their own health care and to eliminate racial and ethnic disparities in health care.

The guide organizes comparative research results according to diabetes patients' concerns and questions and assists them in using research results when talking with health care professionals about their diabetes medicines.

The guide compares 10 generic and 13 brand-name diabetes medications and explains how each works to lower blood sugar, which of them may increase body weight, which may cause side effects such as stomach problems or swelling and each pill's potential effect on "bad" and "good" cholesterol.

The guide also warns patients to be alert for problems such as hypoglycemia -- too-low blood sugar -- which can be caused by certain diabetes pills, as well as other potential side effects. In addition, the guide provides an easy-to-understand comparison of the dose and average cost of each generic and brand-name diabetes medication and the appropriate dose when taken in combination.

Information in the guide is based on the recent AHRQ-funded report, Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults with Type 2 Diabetes. That report, based on scientific evidence found in 216 published studies, summarizes the effectiveness, risks and estimated costs for 10 diabetes medications. It was produced by AHRQ's Effective Health Care Program, an ongoing federal initiative that compares alternative treatments for health conditions. The program is intended to help patients, doctors, nurses and others choose the most effective treatments.

Pastillas para la diabetes tipo 2, the English-language version, Pills for Type 2 Diabetes, and other publications from AHRQ's Effective Health Care Program for consumers and clinicians can be found online at http://effectivehealthcare.ahrq.gov. The consumer guides can be ordered free of charge by sending an e-mail to ahrqpubs@ahrq.hhs.gov or by calling 1-800-358-9295.

Note to Editors: For information on a new, nationwide campaign in Spanish to encourage more adults to visit their doctors for preventive health care to help identify and treat diabetes and other conditions, go to http://www.ahrq.gov/superheroes.


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NINDS Announces New Spanish-Language Website
2. Consumers Union Supports Proposed Expansion of Medicare Policy to Withhold Payments to Hospitals That Harm Patients
3. As Consumers Feel Financial Burden of Increasing Health Care Costs, Health Plans Have Opportunity to Address Unmet Consumer Needs and Become Trusted Advisors
4. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
5. CVS/pharmacy Makes It Easier for Consumers to Save Money and Track Spending with Health Savings and Flexible Spending Accounts
6. LeadCheck(R) Reminds Consumers that Bathtubs are Insidious Source for Dangerous Lead
7. Consumers Urged to Avoid Raw Milk and Raw Milk Products
8. Most States Fail to Protect Consumers Against Insurance Company Abuses
9. Microsoft Announces Alliance to Accelerate Consumer-Centered Delivery of Health and Human Services
10. Consumers Energy and the Michigan Commission on Services to the Aging Celebrate 20 Years of Helping Older Adults
11. Consumers Urged to Avoid Certain Tomatoes Amid Salmonella Scare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... Business Architecture Body of Knowledge (BIZBOK® Guide )v 6.0 is now available for ... this effort through Guild collaborative teams. , Non-members may download the Part ...
(Date:7/20/2017)... ... July 20, 2017 , ... LINET, an international leader ... to their product line: the AVE 2 birthing bed. , Perfectly suitable for labor, ... new level of comfort and efficiency to every phase of childbirth. The AVE 2 ...
(Date:7/20/2017)... TX (PRWEB) , ... July 19, 2017 , ... At ... the availability of temporomandibular joint (TMJ) treatment and dental implants in Waco, ... TRIOS® intraoral scanner and the T-Scan™ by Tekscan®, they can capture details in the ...
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson ... healthcare project manager, Josh Christensen. As a leader in healthcare construction, AP has ... its healthcare resume in the Midwest with Josh now on board. , ...
(Date:7/20/2017)... ... ... a fun-filled, action-packed memoir of adventures. “Fidget” is the creation of published author, Carol ... summa cum laude graduate of Gardner Webb University. She has won numerous awards during ... public school, Lynn continued to pursue her love for music through playing piano, harp, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017  The tenth annual BioPharm ... MA at the Sheraton Boston Hotel, September ... access to global decision makers and innovative biotech startup ... science leaders during two impactful days. BioPharm America is ... with additional networking opportunities with 4,500+ life science industry ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
Breaking Medicine Technology: